Message from the
Chairman of the Board
PlantForm’s Annual General Meeting was held on Sept. 21, 2010. PlantForm’s Board of Directors was reappointed by the shareholders. The Board consists of:
Dr. Mark Goldberg (Chair)
Dr. Donald Stewart (CEO)
Dr. Chris Hall (CSO)
Dr. Jim Rae (external Board member and Chair of the Compensation and Corporate Governance Committee of the Board)
Warren Whitehead, CA (external Board member and Chair of the Audit Committee of the Board)
Please visit our website to view the AGM presentation
New website launched!
Our website has a new look and information for investors, the media and other stakeholders and partners. Check it out at www.plantformcorp.com.
Alethia Biotherapeutics secures $9.6M
Montreal-based company closes Series A round of financing for its therapeutic monoclonal antibody pipeline.
BMS buys ZymoGenetics for $885M
Acquisition strengthens Bristol-Myers Squibb’s Hepatitis C portfolio.
GlaxoSmithKline, Lonza sign deal
Lonza to supply manufacturing capacity for 5 early-stage monoclonal antibodies.
Don Stewart, PhD
President & CEO
Ron Hosking, CA
Chief Financial Officer
Chris Hall, PhD
Chief Scientific Officer